BeiGene Ltd. ADR (BGNE) Social Stream
BEIGENE LTD (BGNE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BEIGENE LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $431 | $343.3 | $404.46 | $207.71 | 94.72% |
| 2022-01-06 | 6 | $431 | $283.3 | $392.46 | $207.71 | 88.95% |
| 2022-01-12 | 6 | $431 | $283.3 | $388.716 | $207.71 | 87.14% |
| 2022-01-18 | 6 | $431 | $283.3 | $380.883 | $207.71 | 83.37% |
| 2022-01-28 | 6 | $431 | $283.3 | $367.55 | $207.71 | 76.95% |
| 2022-02-08 | 6 | $431 | $283.3 | $354.216 | $207.71 | 70.53% |
| 2022-02-25 | 6 | $431 | $283.3 | $348.55 | $207.71 | 67.81% |
| 2022-02-28 | 6 | $431 | $254 | $332.333 | $207.71 | 60% |
| 2022-03-17 | 6 | $431 | $177 | $300.2 | $207.71 | 44.53% |
| 2022-04-28 | 6 | $431 | $177 | $313.166 | $207.71 | 50.77% |
| 2022-05-06 | 6 | $431 | $177 | $296.166 | $207.71 | 42.59% |
| 2022-05-18 | 6 | $431 | $177 | $289.833 | $207.71 | 39.54% |
| 2022-07-27 | 6 | $431 | $177 | $288.666 | $207.71 | 38.98% |
| 2022-08-05 | 6 | $431 | $177 | $284.316 | $207.71 | 36.88% |
| 2022-08-09 | 6 | $431 | $177 | $271.983 | $207.71 | 30.94% |
| 2022-09-17 | 6 | $431 | $177 | $270.6 | $207.71 | 30.28% |
| 2022-10-03 | 6 | $431 | $177 | $269.433 | $207.71 | 29.72% |
| 2022-10-13 | 6 | $296 | $200 | $236.433 | $207.71 | 13.83% |
| 2022-11-14 | 6 | $296 | $205 | $240.266 | $207.71 | 15.67% |
The Trend in the Analyst Price Target
BGNE's average price target has moved down $140.62 over the prior 43 weeks.
Over the past 45 weeks, BGNE's average upside potential has been 67.22%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-17 | 6 | 431 | 177 | 311.833 | 189.04 | 64.96% |
| 2022-04-28 | 6 | 431 | 177 | 313.166 | 158.45 | 97.64% |
| 2022-05-09 | 6 | 431 | 177 | 289.833 | 134.22 | 115.94% |
| 2022-08-12 | 6 | 431 | 177 | 270.600 | 193.97 | 39.51% |
| 2022-10-03 | 6 | 296 | 177 | 237.120 | 137.14 | 72.9% |
BGNE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
BGNE's average broker recommendation rating improved by 0.24 over the prior 32 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BGNE as an investment opportunity.
- In terms of how BEIGENE LTD fares relative to all US stocks, note that its average analyst price target is greater than 2281.69% of that group.
- BEIGENE LTD's number of analysts covering the stock is higher than 219.94% of stocks in the large market cap category.
- BEIGENE LTD's upside potential (average analyst target price relative to current price) is higher than 618.11% of Pharmaceutical Products stocks.
- BEIGENE LTD's variance in analysts' estimates is lower than -1294.69% of stocks in the large market cap category.
In the Pharmaceutical Products industry, GLPG, RARE, and ALKS are the three stocks most similar to BEIGENE LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BGNE? Use POWR Ratings for clearer insight into price direction.